ONCOLife Articles
AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer
AI | 29 November 2024
The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia
FDA & EMA | 27 November 2024
SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer
Clinical Trials | 26 November 2024
How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment
ONCOLife | 27 November 2024
How Novel Immunotherapy IMNN-001 Could Change Ovarian Cancer Outcomes
ONCOLife | 25 November 2024
FDA Greenlights Revumenib for Relapsed Leukemia Treatment
ONCOLife | 23 November 2024
FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer
ONCOLife | 22 November 2024
How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment
ONCOLife | 21 November 2024
IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer
Clinical Trials
7 November 2024
Role of CGP Testing in the Management of Cancer Treatment and Personalized Care
ONCOLife
4 November 2024
Transforming Melanoma Treatment with DNA Plasmid Vaccine
ONCOLife
28 October 2024
AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma
FDA & EMA
17 October 2024
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
FDA & EMA
19 October 2024
FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer
ONCOLife
12 October 2024
Merlin Molecular Test Offers Hope for Melanoma by Reducing Unnecessary Surgeries
Biotech
11 October 2024
Bayer Expands Precision Oncology Portfolio with MOMA Therapeutics' KNOMATIC Platform
ONCOLife
9 October 2024
The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment
ONCOLife
9 October 2024
The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC
ONCOLife
7 October 2024
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
